|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1999-7-22
|
|
pubmed:abstractText |
To explore whether the radioligand 2 beta-carboxymethoxy-3 beta-(4-[123I] iodophenyl) tropane ([123I]beta-CIT) and single-photon emission computed tomography (SPECT) can detect decreased striatal uptake in at-risk relatives of patients with Parkinson disease (PD).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0025-6196
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
681-5
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10405696-Adult,
pubmed-meshheading:10405696-Age Factors,
pubmed-meshheading:10405696-Aged,
pubmed-meshheading:10405696-Aged, 80 and over,
pubmed-meshheading:10405696-Case-Control Studies,
pubmed-meshheading:10405696-Cocaine,
pubmed-meshheading:10405696-Corpus Striatum,
pubmed-meshheading:10405696-Female,
pubmed-meshheading:10405696-Humans,
pubmed-meshheading:10405696-Iodine Radioisotopes,
pubmed-meshheading:10405696-Male,
pubmed-meshheading:10405696-Middle Aged,
pubmed-meshheading:10405696-Parkinson Disease,
pubmed-meshheading:10405696-Risk,
pubmed-meshheading:10405696-Tomography, Emission-Computed,
pubmed-meshheading:10405696-Tomography, Emission-Computed, Single-Photon
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Detection of preclinical Parkinson disease in at-risk family members with use of [123I]beta-CIT and SPECT: an exploratory study.
|
|
pubmed:affiliation |
Department of Neurology, Mayo Clinic Rochester, Minn. 55905, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
